Cargando…
Emerging small molecule antivirals may fit neatly into COVID-19 treatment
Numerous treatments exist for COVID-19, the illness caused by SARS-CoV-2 virus, although most are not well established; among these are several small molecule antiviral agents. Intravenous remdesivir is an established treatment worldwide for inpatients and in some countries is also available for use...
Autores principales: | Fenton, Caroline, Keam, Susan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882464/ https://www.ncbi.nlm.nih.gov/pubmed/35250258 http://dx.doi.org/10.1007/s40267-022-00897-8 |
Ejemplares similares
-
Antidepressants with anti-inflammatory properties may be useful in long COVID depression
por: Fenton, Caroline, et al.
Publicado: (2022) -
COVID-19: State of the Vaccination
por: Fenton, Caroline, et al.
Publicado: (2021) -
Clozapine is the approved option in treatment-resistant schizophrenia and requires careful management
por: Fenton, Caroline, et al.
Publicado: (2023) -
COVID-19 Pandemic Impact on Nursing Student Education: Telenursing with Virtual Clinical Experiences
por: Hargreaves, Linda, et al.
Publicado: (2021) -
Moral Ecology in Nursing: A Pluralistic Approach
por: Copeland, Darcy
Publicado: (2019)